| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.12B | +7.2% |
| Cost of Revenue | $119.0M | +9.1% |
| R&D Expense | $23.1M | +1.6% |
| SG&A Expense | $167.0M | +6.7% |
| Operating Income | $7.5M | -90.0% |
| Pre-tax Income | $30.7M | -65.4% |
| Income Tax | $21.9M | -36.0% |
| Net Income | $8.7M | -84.0% |
| EPS (Basic) | $0.43 | -84.2% |
| EPS (Diluted) | $0.41 | -84.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $515.6M | +25.0% |
| Short-term Investments | $47.9M | -26.9% |
| Accounts Receivable | $134.3M | +0.9% |
| Current Assets | $773.0M | +11.5% |
| Total Assets | $1.19B | +4.6% |
| Current Liabilities | $483.0M | +10.1% |
| Total Liabilities | $741.4M | +9.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $150.4M | +661.5% |
| Capital Expenditures | $26.3M | +95.9% |
| Investing Cash Flow | -$14.6M | -110.9% |
| Financing Cash Flow | -$16.7M | +68.7% |
| Free Cash Flow | $124.1M | +408.6% |
| Stockholders' Equity |
| $452.8M |
| -2.0% |